Sacramento doctor: If not for NIH funding, I wouldn’t have survived my leukemia diagnosis ...
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
Using machine learning tools to detect gene mutations from leukemia cell images
Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve ...
Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...
Science Daily5 天
Leukemia News
Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...
CURE2 天
Orca-T Doubles Graft-Versus-Host Disease-Free Survival in Leukemia
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
BioPharma Dive3 天
Orca Bio to seek approval of T cell transplant after positive trial data
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
Acute Myeloid Leukemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Targeted Oncology8 小时
Lee Evaluates Chronic GVHD Therapies for Depth and Durability of Response
During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...